Dr. John Kuruvilla, MD
Claim this profilePrincess Margaret Cancer Centre
Studies Cancer
Studies Non-Hodgkin's Lymphoma
8 reported clinical trials
18 drugs studied
Area of expertise
1Cancer
Stage IV
CD20 positive
CD22 positive
2Non-Hodgkin's Lymphoma
Stage IV
MYC positive
BCL2 positive
Affiliated Hospitals
Clinical Trials John Kuruvilla, MD is currently running
Pembrolizumab + Bendamustine
for Hodgkin's Lymphoma
This is a phase 2 open-label study to test the safety and effectiveness of combining pembrolizumab and bendamustine in patients with relapsed (cancer that has come back or started getting worse) or refractory (cancer that is not responding or has stopped responding to treatment) Hodgkin lymphoma.
Recruiting1 award Phase 213 criteria
Optimized Lymphodepletion + CAR T Therapy
for Diffuse Large B-Cell Lymphoma
This is a Phase 1b study of participants with Diffuse Large B Cell Lymphoma (DLBCL). The purpose of this study is to identify an optimized lymphodenpletion (LD) regimen by evaluating standard and intermediate doses of Fludarabine (Flu) / Cyclophosphamide (Cy) with or without a fixed dose of total lymphoid irradiation (TLI) in the setting of standard of care CAR T cell therapy.
Recruiting1 award Phase 1
More about John Kuruvilla, MD
Clinical Trial Related9 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments John Kuruvilla, MD has experience with
- Pembrolizumab
- Cyclophosphamide
- Glofitamab
- Bendamustine Hydrochloride
- CTX110
- Cisplatin
Breakdown of trials John Kuruvilla, MD has run
Cancer
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Kuruvilla, MD specialize in?
John Kuruvilla, MD focuses on Cancer and Non-Hodgkin's Lymphoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are CD20 positive.
Is John Kuruvilla, MD currently recruiting for clinical trials?
Yes, John Kuruvilla, MD is currently recruiting for 5 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that John Kuruvilla, MD has studied deeply?
Yes, John Kuruvilla, MD has studied treatments such as Pembrolizumab, Cyclophosphamide, Glofitamab.
What is the best way to schedule an appointment with John Kuruvilla, MD?
Apply for one of the trials that John Kuruvilla, MD is conducting.
What is the office address of John Kuruvilla, MD?
The office of John Kuruvilla, MD is located at: Princess Margaret Cancer Centre, Toronto, Ontario M5G 2M9 Canada. This is the address for their practice at the Princess Margaret Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.